Please join Edwards Lifesciences for a unique opportunity to learn about the future landscape of healthcare, and its impact on TAVR programs. Our expert panelists will share insights on the current and future state of healthcare policy, reimbursement, and Cardiovascular service delivery. Attendees can expect to gain knowledge to better inform their business strategy, and ideas to make the most of unique new opportunities at hand.
Mark Russo, MD | Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ
Dan Mendelson | Avalere Health, Washington, D.C.
Lisa Hathaway Stella | Structural Heart & Vascular, New York-Presbyterian/Columbia, NY
Sameer Amin, MD | CareMore/Aspire Health, Los Angeles, CA
The moderator led roundtable discussion will include the following topics:
• The election and the impact of shifting health policy on hospitals
• Enhancement of the TAVR care pathway to maximize patient access to TAVR therapy amidst the pandemic
• Shifting payer mix and the impact on your service line